Skip to main content

Articles

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Page 3 of 49

  1. This observational study aims to describe and compare histopathological, architectural, and nuclear characteristics of sebaceous lesions and utilized these characteristics to develop a predictive classificatio...

    Authors: Kambiz Kamyab-Hesari, Vahidehsadat Azhari, Ali Ahmadzade, Fahimeh Asadi Amoli, Anahita Najafi, Alireza Hasanzadeh and Alireza Beikmarzehei
    Citation: Diagnostic Pathology 2023 18:89
  2. To determine the predictive indexes of late cervical lymph node metastasis in early tongue squamous cell carcinoma (TSCC). We retrospectively analyzed the cases of 25 patients with stage I/II TSCC who had unde...

    Authors: Koroku Kato, Hiroki Miyazawa, Hisano Kobayashi, Yoshiaki Kishikawa, Hayato Funaki, Natsuyo Noguchi, Kazuhiro Ooi and Shuichi Kawashiri
    Citation: Diagnostic Pathology 2023 18:87
  3. ALES is a rare subtype that demonstrates the EWSR1-FLI1 translocation characteristic of ES and demonstrates complex epithelial differentiation including diffuse cytokeratin and p40 expression. It has predomina...

    Authors: Zhe Wang, Xiaobo Wen, Yingchun Zhang and Xinke Zhang
    Citation: Diagnostic Pathology 2023 18:86
  4. A pediatric patient suffered from renal and hepatic abscesses (through hepatorenal space) and recovered by antibiotics and other therapies. By clinical analysis, the multi-organ abscesses might be caused by bl...

    Authors: Mingkun Wu, Haijuan Xiao, Yan Xiao, Tianming Chen, Xinming Wang, Xia Xiao, Ying Wang, Jianwei Wang, Lili Ren and Gang Liu
    Citation: Diagnostic Pathology 2023 18:85
  5. Desmoplastic small round-cell tumors (DSRCT) frequently develop in the retroperitoneum, pelvis, omentum, and mesentery. Here, we present an unusual case of primary DSRCT in the liver. The patient was an 11-yea...

    Authors: Xiao Feng, Jing Tao, Qiang Zhou, Yi-Dan Qiao, Le-Jian He and Nan Zhang
    Citation: Diagnostic Pathology 2023 18:84
  6. The incidental finding of thyroid inclusions in lymph nodes of neck dissections of non-thyroid cancer patients is an unusual event. It is still controversial for pathologists about whether this represents beni...

    Authors: Chunfang Hu, Haifeng Zhang, Lixia Chu, Tian Qiu and Haizhen Lu
    Citation: Diagnostic Pathology 2023 18:82
  7. Epstein–Barr virus (EBV)-associated gastric cancer exhibits distinct clinicopathologic characteristics, showing a good response to immune checkpoint inhibitors and a favorable prognosis. However, gastric cance...

    Authors: Ki Bum Park, An Na Seo and Moonsik Kim
    Citation: Diagnostic Pathology 2023 18:81
  8. Urothelial carcinoma is a major subtype of bladder cancer and small cell carcinoma (SCC) is a rare type of cancer in clinical practice. Pathologic collision of urinary bladder urothelial carcinoma with SCC is ...

    Authors: Wei Jiang, Chi Pan, Wei Guo, Zhen Xu, Qingtao Ni and Yashi Ruan
    Citation: Diagnostic Pathology 2023 18:80
  9. To investigate the characteristics of reticular fibre structure (RFS) in parathyroid adenoma (PTA), atypical parathyroid tumour (APT), and parathyroid carcinoma (PTC), and to assess its value as a diagnostic i...

    Authors: Xiumei Hu, Shurong He, Xingran Jiang, Ping Wei, Xiang Zhou, Zhongyue Shi, Xue Li, Jun Lu, Hongying Zhao, Bojun Wei and Mulan Jin
    Citation: Diagnostic Pathology 2023 18:79
  10. Composite haemangioendothelioma is a rare vascular neoplasm with indolent to intermediate malignant potential. Diagnosis of this disease relays on histopathological identification of at least two different mor...

    Authors: Jan Balko, Andrej Ozaniak, Lenka Krskova, Zuzana Strizova, Robert Lischke and Josef Zamecnik
    Citation: Diagnostic Pathology 2023 18:76
  11. Human epidermal growth factor receptor 2 (HER2), a promising therapeutic target, can be mutated, amplified, or overexpressed in different malignancies, including non-small cell lung cancer (NSCLC). Although th...

    Authors: Ola Abu Al Karsaneh, Arwa Al Anber, Mohammad ALQudah, Sahar Al-Mustafa, Hussien AlMa’aitah and Maher Sughayer
    Citation: Diagnostic Pathology 2023 18:75
  12. Only one thyroid follicular cell-derived tumor with a purely trabecular growth pattern has previously been described. This report aims to describe the histological, immunohistochemical, and molecular findings ...

    Authors: Mitsuyoshi Hirokawa, Michiko Matsuse, Norisato Mitsutake, Ayana Suzuki, Miyoko Higuchi, Toshitetsu Hayashi, Hiroshi Kamma, Akira Miyauchi and Takashi Akamizu
    Citation: Diagnostic Pathology 2023 18:74
  13. Abdominal aortic aneurysm (AAA) is a pathologic enlargement of the infrarenal aorta with an associated risk of rupture. However, the responsible mechanisms are only partially understood. Based on murine and hu...

    Authors: Anna-Leonie Menges, Maja Nackenhorst, Johannes R. Müller, Marie-Luise Engl, Renate Hegenloh, Jaroslav Pelisek, Ellen Geibelt, Anja Hofmann, Christian Reeps, Gabor Biro, Hans-Henning Eckstein, Alexander Zimmermann, Derek Magee, Martin Falk, Nadja Sachs and Albert Busch
    Citation: Diagnostic Pathology 2023 18:73

    The Correction to this article has been published in Diagnostic Pathology 2023 18:130

  14. Molecular aberrations occurring in primary ovarian clear cell carcinoma (OCCC) can be of diagnostic, predictive, and prognostic significance. However, a complex molecular study including genomic and transcript...

    Authors: Ivana Stružinská, Nikola Hájková, Jan Hojný, Eva Krkavcová, Romana Michálková, Jiří Dvořák, Kristýna Němejcová, Radoslav Matěj, Jan Laco, Jana Drozenová, Pavel Fabian, Jitka Hausnerová, Gábor Méhes, Petr Škapa, Marián Švajdler, David Cibula…
    Citation: Diagnostic Pathology 2023 18:72
  15. ROS1 fusion is an infrequent, but attractive target for therapy in patients with metastatic non- small-cell lung cancer. In studies on mainly late-stage disease, the prevalence of ROS1 fusions is about 1–3%. I...

    Authors: Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Joakim Oliu Moe, Inger Johanne Zwicky Eide, Marius Lund-Iversen and Odd Terje Brustugun
    Citation: Diagnostic Pathology 2023 18:70
  16. Primary thyroid lymphoma (PTL) is a rare cancer accounting for approximately 5% of thyroid malignancies. Historically, incisional biopsy has been the gold standard for definitive diagnosis of PTL, however, the...

    Authors: Alexander D. Karabachev, William J. Brundage, Mirabelle B. Sajisevi and Allison L. Ciolino
    Citation: Diagnostic Pathology 2023 18:69
  17. Low- and middle-income countries (LMICs) represent a big source of data not only for endemic diseases but also for neoplasms. Data is the fuel which drives the modern era. Data when stored in digital form can ...

    Authors: Talat Zehra, Anil Parwani, Jamshid Abdul-Ghafar and Zubair Ahmad
    Citation: Diagnostic Pathology 2023 18:68
  18. Deep learning models applied to healthcare applications including digital pathology have been increasing their scope and importance in recent years. Many of these models have been trained on The Cancer Genome ...

    Authors: Taher Dehkharghanian, Azam Asilian Bidgoli, Abtin Riasatian, Pooria Mazaheri, Clinton J. V. Campbell, Liron Pantanowitz, H. R. Tizhoosh and Shahryar Rahnamayan
    Citation: Diagnostic Pathology 2023 18:67
  19. Mesothelioma, with various clinical manifestations, radiological features, and histomorphological types, can be divided into epithelioid, sarcomatoid, and biphasic types, according to their histomorphological ...

    Authors: Wang RanYue, Wu ChunYan, Hou Likun, Zhang LiPing, Lin JieLu and Dong ZhengWei
    Citation: Diagnostic Pathology 2023 18:64
  20. Authors: Jung Hee Lee, Yong Jun Kim, Hyun Woo Ryu, Seung Won Shin, Eun Ji Kim, So Hyun Shin, Joon Young Park, So Young Kim, Chung Su Hwang, Joo‑Young Na, Dong Hoon Shin, Jee Yeon Kim and Hyun Jung Lee
    Citation: Diagnostic Pathology 2023 18:63

    The original article was published in Diagnostic Pathology 2023 18:36

  21. SMARCA4-deficient undifferentiated uterine sarcoma (SDUS) is a highly invasive single-gene malignant tumor caused by mutations in the SMARCA4 gene. SDUS has a poor prognosis, with no established treatment strateg...

    Authors: Jie Gao, Ruirui Fan, Dahong Chen, Jinlin Hou, Hanlin Chen and Mingzhi Lu
    Citation: Diagnostic Pathology 2023 18:62
  22. Testicular Sertoli cell tumor (SCT) is very rare sex cord-gonadal stromal tumor, and sclerosing SCT (SSCT) is even rarer. So far, no more than 50 cases of SSCT have been reported. 80% of SSCTs are less than 2 ...

    Authors: Xueyao Tang, Yifan Hu, Hong Zhou and Yang Zhou
    Citation: Diagnostic Pathology 2023 18:61
  23. Cancer metastasis to the kidney is a rare event. We retrospectively analyzed clinicopathologic characteristics in 6 cases of diagnosed renal metastases from primary lung cancer. We also provide clinical follow...

    Authors: Hui Lian, Xinyu Pan, Bo Hong, Jie Min and Fengbo Huang
    Citation: Diagnostic Pathology 2023 18:60
  24. Spindle cell tumors, called solitary fibrous tumors (SFTs), are of mesenchymal origin, and can develop in the orbit. As ‘intermediate malignancy’ tumors, only a small percentage show malignant behavior, such a...

    Authors: Qi Zhou, Yuting Liu, Fang Wang, Yang Cao, Hongbin Lv and Xibo Zhang
    Citation: Diagnostic Pathology 2023 18:59
  25. Authors: Bindu H. Akkanti, Rahat Hussain, Manish K. Patel, Jayeshkumar A. Patel, Kha Dinh, Bihong Zhao, Shaimaa Elzamly, Kevin Pelicon, Klemen Petek, Ismael A. Salas de Armas, Mehmet Akay, Biswajit Kar, Igor D. Gregoric and L. Maximilian Buja
    Citation: Diagnostic Pathology 2023 18:58

    The original article was published in Diagnostic Pathology 2020 15:83

  26. Angiomyolipoma is a benign mesenchymal neoplasm of a wide histological heterogeneity belonging to the PEComa “family.” The liver, after the kidney, is their second most frequent location. However, inflammatory...

    Authors: Francisco Javier Velasco-Albendea, María Jesús Gil-Belmonte, Beatriz Estébanez-Ferrero, Orlando Fuentes-Porcel and Bruno José Nievas-Soriano
    Citation: Diagnostic Pathology 2023 18:57
  27. The concept of critical value is not evident in surgical pathology, and there is no established protocol for determining, reporting, and documenting these results.

    Authors: Neda Soleimani, Atefe Zare Sheibani, Samira Khajeh, Sahand Mohammadzadeh, Negar Taheri, Maral Mokhtari, Mahsa Farhadi, Zahra Hajizade, Saeideh Khaleghpanah and Sima Dehghani
    Citation: Diagnostic Pathology 2023 18:55
  28. Histomorphological differentiation between pancreatic serous cystadenoma (SCA) and clear cell renal cell carcinoma (RCC) can be challenging. We aimed to study Paired box 8 protein (Pax8) expression profile in ...

    Authors: Zhikai Chi, Jing Xu, Dipti M. Karamchandani and Lan Peng
    Citation: Diagnostic Pathology 2023 18:54
  29. Eosinophilic solid and cystic renal cell carcinoma (ESC-RCC) is an under-recognized, emerging new entity of sporadic renal neoplasms, which is listed as a rare type of renal cell carcinoma in the 2022 WHO rena...

    Authors: Xin He, Ying Chen, Hao Tang, Yujuan Xu, Xingyan Zhu, Caihong Wang, Qiang Chen and Deyu Guo
    Citation: Diagnostic Pathology 2023 18:53
  30. Breast-implant associated (BIA) lymphoma is an infrequent type of cancer occurring in the fluid and fibrous capsule around a textured breast implant. Recently, both the 2022 WHO 5th edition classification of H...

    Authors: Johanna Vets, Lukas Marcelis, Charlotte Schepers, Yaliva Dorreman, Sanne Verbeek, Lieve Vanwalleghem, Katrien Gieraerts, Liesbeth Meylaerts, Jan Lesaffer, Helena Devos, Natalie Put, Sylvia Snauwaert, Pascale De Paepe and Thomas Tousseyn
    Citation: Diagnostic Pathology 2023 18:52
  31. Head and neck squamous cell carcinoma (HNSCC) is a multisite malignancy that responds well to immunotherapy. Despite the initial enthusiasm, the clinical benefits of immunotherapy in HNSCC patients are overall...

    Authors: Xinlong Fan, Xiao Yang, Nan Guo, Xin Gao and Yuejiao Zhao
    Citation: Diagnostic Pathology 2023 18:51
  32. Mucinous carcinoma (MC) is a histological subtype of ovarian cancer that has a worse prognosis at advanced stages than the most prevalent histological subtype, high-grade serous carcinomas. Invasive patterns h...

    Authors: Taira Hada, Morikazu Miyamoto, Yuka Ohtsuka, Jin Suminokura, Tsubasa Ito, Naohisa Kishimoto, Soko Nishitani, Minori Takada, Akari Imauji, Risa Tanabe and Masashi Takano
    Citation: Diagnostic Pathology 2023 18:49
  33. Determination of programmed death-ligand 1 (PD-L1) protein expression level in tumor cells and tumor-associated immune cells is critical for identifying patients eligible for immunotherapy. PD-L1 manual scorin...

    Authors: Chunyan Liu, Fang Fang, Ying Kong and Ehab A. ElGabry
    Citation: Diagnostic Pathology 2023 18:48
  34. Struma ovarii is an unusual ovarian teratoma containing predominantly thyroid tissue. Less than 10% of cases undergo malignant transformation in the thyroid tissue and are considered malignant struma ovarii (M...

    Authors: Gabriella T. Seo, Jeremy Minkowitz, Danielle A. Kapustin, Jun Fan, Gerald Minkowitz, Miriam Minkowitz, Eric Dowling, Ammar Matloob, Divya Asti, Meekoo Dhar, Christopher Shutty, Alan Brickman, Mark L. Urken, Margaret Brandwein-Weber and Sydney D. Finkelstein
    Citation: Diagnostic Pathology 2023 18:47
  35. Hypoxia is a characteristic of many solid tumours and an adverse prognostic factor for cancer therapy. Hypoxia results in upregulation of carbonic anhydrase IX (CAIX) expression, a pH-regulating enzyme. Many h...

    Authors: Suad A. K. Shamis, Joanne Edwards and Donald C. McMillan
    Citation: Diagnostic Pathology 2023 18:46
  36. Malignant perivascular epithelioid cell tumors (PEComas) are exceedingly rare malignant mesenchymal neoplasms with characteristic morphological and immunohistochemical (IHC) patterns. However, some malignant P...

    Authors: Luke Meredith, Timothy Chao, Avinoam Nevler, Atrayee Basu Mallick, Rajan K. Singla, Peter A. McCue, Wilbur B. Bowne and Wei Jiang
    Citation: Diagnostic Pathology 2023 18:45
  37. Low-grade papillary Schneiderian carcinoma (LGPSC) is a relatively new entity of the sinonasal tract and is characterized by a bland morphology simulating sinonasal papilloma, invasive growth pattern with push...

    Authors: Sayaka Yuzawa, Tomohiko Michizuka, Rika Kakisaka, Yusuke Ono, Manami Hayashi, Miki Takahara, Akihiro Katada, Yusuke Mizukami and Mishie Tanino
    Citation: Diagnostic Pathology 2023 18:44
  38. PTEN hamartoma tumour syndrome (PHTS) is a rare hereditary disorder caused by germline pathogenic mutations in the PTEN gene. This study presents a case of PHTS referred for genetic evaluation due to multiple pol...

    Authors: Zahra Rahmatinejad, Ladan Goshayeshi, Robert Bergquist, Lena Goshayeshi, Amin Golabpour and Benyamin Hoseini
    Citation: Diagnostic Pathology 2023 18:43
  39. Splenogonadal fusion (SGF) is a rare congenital malformation in which the spleen is abnormally connected to the gonads or to the mesonephric derivatives. There is no obvious causality between SGF and testicula...

    Authors: Donglai Shen, Yuzhu Li, Yu Zhang, Xiao Chang, Xupeng Zhao, Jiabin Li, Xu Zhang and Gang Guo
    Citation: Diagnostic Pathology 2023 18:42
  40. Epithelioid and spindle rhabdomyosarcoma (ES-RMS) with TFCP2 rearrangement is a recently discovered rare variant of rhabdomyosarcoma composed of epithelioid and spindle cells, because it shows extraordinarily ...

    Authors: Yuan Li, Dan Li, Jingyu Wang and Jinlong Tang
    Citation: Diagnostic Pathology 2023 18:41
  41. Complete and partial moles (PM) are the most common gestational trophoblastic diseases. Due to some overlapping morphological findings, ancillary studies may be necessary.

    Authors: Behnaz Jahanbin, Soheila Sarmadi, Dorsa Ghasemi, Fatemeh Nili, Jafar-Ali Moradi and Soha Ghasemi
    Citation: Diagnostic Pathology 2023 18:40

Annual Journal Metrics

  • 2022 Citation Impact
    2.6 - 2-year Impact Factor
    2.7 - 5-year Impact Factor
    1.096 - SNIP (Source Normalized Impact per Paper)
    0.677 - SJR (SCImago Journal Rank)

    2023 Speed
    22 days submission to first editorial decision for all manuscripts (Median)
    119 days submission to accept (Median)

    2023 Usage 
    1,109,481 downloads
    429 Altmetric mentions